Steven Borst

Mr. Borst serves as President, Chief Executive Officer, and Chairman of Q Therapeutics, Inc. He has led the financial and corporate development activities of the Company since its inception.

Mr. Borst has over 30 years of company formation and operating experience in the life sciences sector with a specific focus on biotechnology and medical devices since 2001. He has served in senior executive positions and business development roles including CEO of ACT/PC (NASDAQ:MCK), and VP Business Development of American WholeHealth (NASDAQ:HWAY).

Mr. Borst has worked as a venture capital investor, partnering in early-stage equity investments in Cytyc (NASDAQ:HOLX), Sunrise Senior Living (formerly Sunrise Assisted Living – SNRZ), and US Servis (NASDAQ:MCK).

He holds a Bachelor of Science (Industrial Engineering and Operations Research) from the University of Michigan and a Master of Management degree from Northwestern University’s J.L. Kellogg Graduate School of Management.